ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,215
Screening encounters
2,403
Diagnostic referrals
462
Outstanding pathways
195

Screening pathway

  1. Screening2,403Encounters
  2. Positive finding805Documented findings
  3. Referral462Diagnostic referrals
  4. Follow-up515Diagnostic visits
  5. Outcome267Resolved pathways

Stage totals use different units. Pending pathways: 195. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2828 · EXP-2828Synthetic · Site C

Full participant history through 2026-01-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA technically uninterpretable · Inadequate
  3. · Repeat plan · VIA · Inadequate result · Scheduled for 2025-06-21
  4. · Screening · VIA · Repeat · Inadequate result
  5. · Screening result · VIA · VIA positive · Adequate
  6. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-12-30
  7. · Diagnostic referral · EXP-2828-T-R
  8. · Contact attempt · Unsuccessful
  9. · Barrier documented · Transport difficulty
  10. · Diagnostic booking · Initial booking
  11. · Contact attempt · Reached
  12. · Diagnostic visit · Missed
  13. · Diagnostic booking · Rebooking
  14. · Diagnostic visit · Attended
  15. · Diagnosis · Colposcopy · Biopsy collected
  16. · Diagnosis · Histopathology · No high-grade lesion identified
  17. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-10-11
  18. · Follow-up disposition · Resolved · EXP-2828-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2215 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2641 · Expanded synthetic participant 2641Site B — Peri-Urban Access Programme
EXP-2643 · Expanded synthetic participant 2643Site A — Urban Referral Hub
EXP-2644 · Expanded synthetic participant 2644Site C — Rural Outreach Programme
EXP-2647 · Expanded synthetic participant 2647Site E — Resource-Constrained Navigation Programme
EXP-2651 · Expanded synthetic participant 2651Site E — Resource-Constrained Navigation Programme
EXP-2653 · Expanded synthetic participant 2653Site D — Community Engagement Programme
EXP-2655 · Expanded synthetic participant 2655Site D — Community Engagement Programme
EXP-2656 · Expanded synthetic participant 2656Site B — Peri-Urban Access Programme
EXP-2658 · Expanded synthetic participant 2658Site E — Resource-Constrained Navigation Programme
EXP-2659 · Expanded synthetic participant 2659Site E — Resource-Constrained Navigation Programme
EXP-2661 · Expanded synthetic participant 2661Site C — Rural Outreach Programme
EXP-2662 · Expanded synthetic participant 2662Site C — Rural Outreach Programme
EXP-2663 · Expanded synthetic participant 2663Site B — Peri-Urban Access Programme
EXP-2665 · Expanded synthetic participant 2665Site E — Resource-Constrained Navigation Programme
EXP-2666 · Expanded synthetic participant 2666Site B — Peri-Urban Access Programme
EXP-2668 · Expanded synthetic participant 2668Site A — Urban Referral Hub
EXP-2672 · Expanded synthetic participant 2672Site C — Rural Outreach Programme
EXP-2677 · Expanded synthetic participant 2677Site A — Urban Referral Hub
EXP-2678 · Expanded synthetic participant 2678Site A — Urban Referral Hub
EXP-2680 · Expanded synthetic participant 2680Site E — Resource-Constrained Navigation Programme
EXP-2682 · Expanded synthetic participant 2682Site B — Peri-Urban Access Programme
EXP-2686 · Expanded synthetic participant 2686Site D — Community Engagement Programme
EXP-2688 · Expanded synthetic participant 2688Site B — Peri-Urban Access Programme
EXP-2690 · Expanded synthetic participant 2690Site A — Urban Referral Hub
EXP-2691 · Expanded synthetic participant 2691Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1008
HPV DNA
1037
Cytology
358

Navigation activity

Barrier documented
397
Contact attempt
679
Navigation intervention
164
Diagnostic booking
572
Diagnostic visit
515

Documented barriers

Contact difficulty
125
Transport difficulty
133
Appointment coordination
139

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.